Linagliptin approved for type 2 diabetes

被引:0
|
作者
Traynor, Kate
机构
关键词
D O I
10.2146/news110038
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:1059 / 1059
页数:1
相关论文
共 50 条
  • [31] EFFECTS OF LINAGLIPTIN ON RENAL ENDOTHELIAL FUNCTION IN TYPE-2 DIABETES
    Ott, C.
    Kistner, I.
    Keller, M.
    Friedrich, S.
    Bramlage, P.
    Schmieder, R. E.
    JOURNAL OF HYPERTENSION, 2015, 33 : E173 - E173
  • [32] Linagliptin in the Management of Type 2 Diabetes Mellitus After Kidney Transplant
    Attallah, Nizar
    Yassine, Lina
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (07) : 2234 - 2237
  • [33] Linagliptin A Review of its Use in the Management of Type 2 Diabetes Mellitus
    Deeks, Emma D.
    DRUGS, 2012, 72 (13) : 1793 - 1824
  • [34] Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
    Silke Retlich
    Vincent Duval
    Ulrike Graefe-Mody
    Christian Friedrich
    Sanjay Patel
    Ulrich Jaehde
    Alexander Staab
    Clinical Pharmacokinetics, 2015, 54 : 737 - 750
  • [35] Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation
    Barnett, Anthony H.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 149 - 159
  • [36] Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
    Retlich, Silke
    Duval, Vincent
    Graefe-Mody, Ulrike
    Friedrich, Christian
    Patel, Sanjay
    Jaehde, Ulrich
    Staab, Alexander
    CLINICAL PHARMACOKINETICS, 2015, 54 (07) : 737 - 750
  • [37] Pharmacology, Efficacy, and Safety of Linagliptin for the Treatment of Type 2 Diabetes Mellitus
    Neumiller, Joshua J.
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (03) : 358 - 367
  • [38] Linagliptin as add-on therapy to insulin for patients with type 2 diabetes
    von Websky, Karoline
    Reichetzeder, Christoph
    Hocher, Berthold
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 681 - 694
  • [39] Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials
    McGill, Janet B.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2012, 3 (04) : 113 - 124
  • [40] Review of approved pioglitazone combinations for type 2 diabetes
    Forst, Thomas
    Hanefeld, Markolf
    Pfuetzner, Andreas
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (10) : 1571 - 1584